| John P. Neuhaus, M.d., Llc | |
|
99-128 Aiea Heights Drive #301 Aiea HI 96701-3933 | |
| (808) 723-9344 | |
| (808) 312-4637 |
| Full Name | John P. Neuhaus, M.d., Llc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 99-128 Aiea Heights Drive, Aiea, Hawaii |
| Authorized Official Name and Position | John Patrick Neuhaus (OWNER) |
| Authorized Official Contact | 8087239344 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| John P. Neuhaus, M.d., Llc 99-128 Aiea Heights Drive #301 Aiea HI 96701-3933 Ph: (808) 723-9344 | John P. Neuhaus, M.d., Llc 99-128 Aiea Heights Drive #301 Aiea HI 96701-3933 Ph: (808) 723-9344 |
| NPI Number | 1003292012 |
|---|---|
| Provider Enumeration Date | 08/03/2015 |
| Last Update Date | 08/03/2015 |
| Medicare PECOS PAC ID | 4587959408 |
|---|---|
| Medicare Enrollment ID | O20160817000486 |
News Archive
A University of Houston environmental engineer will test parts of Galveston Bay for toxic chemicals in an effort to help state officials determine the best way to handle those pollutants.
Topics Range from Composite Structures to Personnel Decisions to Metastatic Cancer Progression / About Eleven Million Euros in Funding for Three Years
Ipsen, an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22.5 mg 6-month sustained-release formulation for the treatment of locally advanced or metastatic hormone-dependent prostate cancer.
Researchers are suggesting new ways to use existing Internet tools to recruit more study participants for clinical pain trials and to increase the likelihood they will remain throughout the study period.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003292012 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | MD-8427 (Hawaii) | Primary |
| Provider Name | John Neuhaus |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1700085321 PECOS PAC ID: 5991845620 Enrollment ID: I20091210000511 |
News Archive
A University of Houston environmental engineer will test parts of Galveston Bay for toxic chemicals in an effort to help state officials determine the best way to handle those pollutants.
Topics Range from Composite Structures to Personnel Decisions to Metastatic Cancer Progression / About Eleven Million Euros in Funding for Three Years
Ipsen, an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22.5 mg 6-month sustained-release formulation for the treatment of locally advanced or metastatic hormone-dependent prostate cancer.
Researchers are suggesting new ways to use existing Internet tools to recruit more study participants for clinical pain trials and to increase the likelihood they will remain throughout the study period.
› Verified 4 days ago
News Archive
A University of Houston environmental engineer will test parts of Galveston Bay for toxic chemicals in an effort to help state officials determine the best way to handle those pollutants.
Topics Range from Composite Structures to Personnel Decisions to Metastatic Cancer Progression / About Eleven Million Euros in Funding for Three Years
Ipsen, an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22.5 mg 6-month sustained-release formulation for the treatment of locally advanced or metastatic hormone-dependent prostate cancer.
Researchers are suggesting new ways to use existing Internet tools to recruit more study participants for clinical pain trials and to increase the likelihood they will remain throughout the study period.
› Verified 4 days ago
Val J. Umphress, Ph.d., Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 98-211 Pali Momi St, Suite 810, Aiea, HI 96701 Phone: 808-488-9288 Fax: 808-488-9288 | |
Tui L. Ulu Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 98-211 Pali Momi St, Suite 600, Aiea, HI 96701 Phone: 808-282-7201 | |
Michele Wang, Md Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 99-128 Aiea Heights Dr Ste 109, Aiea, HI 96701 Phone: 424-234-3066 | |
Autism Behavior Consulting Group, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 99-950 Iwaena St Fl 2, Aiea, HI 96701 Phone: 808-277-7736 Fax: 808-748-0202 | |
Imua Health Group, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 99-080 Kauhale St Ste C20, Aiea, HI 96701 Phone: 808-953-4682 | |
Living Well Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 98-084 Kamehameha Hwy, Suite 304, Aiea, HI 96701 Phone: 808-486-1020 |